
Overall, healthcare and biotech were both up today, with biotech being the biggest gainer. IBB, the biotechnology ETF, was up nearly 3% today, whereas the overall healthcare sector ETF XLV was up about 0.70% as of the time of recording this content. This marks a sharp change of sentiment, since XLV has been more bullish overall for the last three quarters than has biotech, suggesting the biotechs are being bought up on the lows after sharply declining in October. GERN was a particularly bullish case today, trading up over 17% during the session. Here’s a recap of what happened.